Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
Otherwise generally well tolerated
10.1016/j.biopha.2020.110301 26 HanY.YuanC.ZhouX.HanY.HeY.OuyangJ.et al (2021)
| 05.20.26 | 14 min read
In a statement to CBS News Detroit, the company said it is ending coverage of GLP-1 drugs "for large group fully insured members beginning January 1, 2025, or on a group's 2025 health coverage renewal date." Additionally, the company said it will change prior authorization requirements for Saxenda, Wegovy and Zepbound beginning Aug
W.SmithD
US$ 26.25
US$ 27.00
US$ 21.98
US$ 21.23
US$ 27.04
US$ 22.38
US$ 20.18
US$ 20.76
US$ 26.98
US$ 24.59
US$ 29.55
